CDF Partners with Mediaplanet in Autoimmune Diseases Digital Campaign
The Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.
Continue ReadingThe Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.
Continue ReadingThe Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.
Continue ReadingThe NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.
Continue ReadingAnokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingFody Food Co. announces its continued support of the Celiac Disease Foundation and the celiac community with its wide range of certified gluten-free and Low Fodmap products.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingWe are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.
Continue ReadingRep. Betty McCollum (D-MN) and Rep. Steve Stivers (D-OH) announced the formation of the Congressional Celiac Disease Caucus at the 2021 Celiac Disease Foundation Patient Education & Advocacy Summit.
Continue ReadingHear from the Foundation’s CEO, Marilyn G. Geller, on today’s episode of the Celiac Project Podcast! Learn all about our groundbreaking Patient Education and Advocacy Summit, the monumental ways CDF is helping to advance legislation and research for celiac disease.
Continue ReadingThe Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.
Continue Reading